TY - JOUR
T1 - Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis
AU - Kikuchi, Hitoshi
AU - Yamada, Takeshi
AU - Furuya, Hirokazu
AU - Doh-Ura, Katsumi
AU - Ohyagi, Yasumasa
AU - Iwaki, Toru
AU - Kira, Jun Ichi
N1 - Funding Information:
Acknowledgements A part of this study was carried out at the Morphology Core, Graduate School of Medical Sciences, Kyushu University. This work was supported by a grant of the Nakabayashi Trust for ALS research.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2003/5/1
Y1 - 2003/5/1
N2 - Abnormal proteolysis may be involved in the motor neuron degeneration of amyotrophic lateral sclerosis (ALS). Although several studies of the ubiquitin-proteasome system in ALS have been reported, the endosome-lysosome system has not been investigated in detail. To clarify the association of neurodegeneration with the endosome-lysosome system in ALS, we examined the pathological expression of cysteine proteases such as cathepsins B, H and L and an aspartate protease, cathepsin D, in the anterior horns of 15 ALS cases and 5 controls. In the ALS cases, cathepsin B immunoreactivity was preferentially decreased in the lateral parts of the anterior gray horns compared with the controls. Its immunoreactivity was increased in the cytoplasm of both shrunken and pigmented neurons but was weak in the neurons containing Bunina bodies. In addition, reactive astrocytes were also immunolabeled with cathepsin B. Cathepsin H and cathepsin L were detected in the cytoplasm of a small number of shrunken and pigmented neurons. Cathepsin D immunoreactivity was strong in the cytoplasm of all motor neurons. The immunoreactivity of cathepsins H, L and D was not significantly different between control and ALS cases. Western blot analysis showed that the 25-kDa activated form of cathepsin B was down-regulated in ALS. Our results suggest that cathepsin B is involved in the motor neuron degeneration in ALS.
AB - Abnormal proteolysis may be involved in the motor neuron degeneration of amyotrophic lateral sclerosis (ALS). Although several studies of the ubiquitin-proteasome system in ALS have been reported, the endosome-lysosome system has not been investigated in detail. To clarify the association of neurodegeneration with the endosome-lysosome system in ALS, we examined the pathological expression of cysteine proteases such as cathepsins B, H and L and an aspartate protease, cathepsin D, in the anterior horns of 15 ALS cases and 5 controls. In the ALS cases, cathepsin B immunoreactivity was preferentially decreased in the lateral parts of the anterior gray horns compared with the controls. Its immunoreactivity was increased in the cytoplasm of both shrunken and pigmented neurons but was weak in the neurons containing Bunina bodies. In addition, reactive astrocytes were also immunolabeled with cathepsin B. Cathepsin H and cathepsin L were detected in the cytoplasm of a small number of shrunken and pigmented neurons. Cathepsin D immunoreactivity was strong in the cytoplasm of all motor neurons. The immunoreactivity of cathepsins H, L and D was not significantly different between control and ALS cases. Western blot analysis showed that the 25-kDa activated form of cathepsin B was down-regulated in ALS. Our results suggest that cathepsin B is involved in the motor neuron degeneration in ALS.
UR - http://www.scopus.com/inward/record.url?scp=0038388993&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038388993&partnerID=8YFLogxK
U2 - 10.1007/s00401-002-0667-9
DO - 10.1007/s00401-002-0667-9
M3 - Article
C2 - 12677446
AN - SCOPUS:0038388993
SN - 0001-6322
VL - 105
SP - 462
EP - 468
JO - Acta Neuropathologica
JF - Acta Neuropathologica
IS - 5
ER -